Compass Therapeutics | 4:持股变动声明-高管 Anderman Jonathan
Compass Therapeutics | 3:首次持股声明-高管 Anderman Jonathan
Compass Therapeutics | SC 13G:超过5%持股股东披露文件-Blackstone Inc.(6.9%),Blackstone Group Management L.L.C.(6.9%)等
Compass Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-OrbiMed Advisors LLC(13.7%),OrbiMed Capital GP V LLC(11.1%)等
Compass Therapeutics | 4:持股变动声明-董事 Boylan James P
Compass Therapeutics | 4:持股变动声明-董事 GORDON CARL L
Compass Therapeutics | 4:持股变动声明-董事 GRAY MARY ANN
Compass Therapeutics | 4:持股变动声明-董事 LINDAHL RICHARD S
Compass Therapeutics | 4:持股变动声明-董事 Ferneau Philip
Compass Therapeutics | 4:持股变动声明-董事 Chiniara Ellen
Compass Therapeutics | 4:持股变动声明-高管 Bisker-Leib Vered
Compass Therapeutics | 4:持股变动声明-高管 Schuetz Thomas J.
Compass Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(3.570%),Abigail P. Johnson(3.570%)
Compass Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Adage Capital Partners, L.P.(7.75%),Adage Capital Partners GP, L.L.C.(7.75%)等
Compass Therapeutics | SC 13G:超过5%持股股东披露文件-Janus Henderson Group plc(6.0%),Janus Henderson Biotech Innovation Master Fund Ltd(5.4%)
Compass Therapeutics | 4:持股变动声明-高管 Bisker-Leib Vered
Compass Therapeutics | 4:持股变动声明-高管 Schuetz Thomas J.
Compass Therapeutics | SC 13G:超过5%持股股东披露文件-Adage Capital Partners, L.P.(5.66%),Adage Capital Partners GP, L.L.C.(5.66%)等
Compass Therapeutics | 4:持股变动声明-首席运营官 Bisker-Leib Vered
Compass Therapeutics | 4:持股变动声明-首席执行官 Schuetz Thomas J.
暂无数据
暂无数据